FDA Inspection
Lonza Bend Inc.Lonza Bend Inc. – FDA Inspection, Jul 27, 2018
Record Details
This FDA Inspection record concerns Lonza Bend Inc., with an inspection on July 27, 2018, issued by the Seattle District Office, covering human drugs.
- Office
- Seattle District Office
- People
- Chiaochun J. Wang (Issuing Officer)
- Zachary A. Bogorad
View Company Profile
ID · 73b171a0-00fd-4654-934d-25fbf8b41968
Inspection Facts
- Inspection number
- 1060190
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Lonza Bend Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 19, 2026 | Not classified | Seattle District Office | Drug Quality Assurance |
| May 24, 2023 | VAI | Seattle District Office | |
| August 5, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 27, 2018 | Not classified | Seattle District Office | |
| July 21, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lonza Bend Inc.
- FDA Inspection 1317820 - 2026-05-19
- FDA Inspection 1206164 - 2023-05-24
- FDA Inspection 1178398 - 2022-08-05
- FDA Inspection 1065493 - 2018-07-27
- FDA Inspection 1018924 - 2017-07-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.